Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Deciphera Pharmaceuticals, Inc. (DCPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2020 |
GN
| China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor |
| 06/11/2019 |
GN
| Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China |
| 03/06/2019 |
GN
| Market Trends Toward New Normal in Exelon, AT&T, United States Cellular, Deciphera Pharmaceuticals, Boyd Gaming, and Argo Group International — Emerging Consolidated Expectations, Analyst Ratings |
| 12/27/2018 |
GN
| Report: Developing Opportunities within AutoZone, Deciphera Pharmaceuticals, Clearwater Paper, Churchill Downs, Whitestone REIT, and ZTO Express (Cayman) — Future Expectations, Projections Moving into 2019 |
| 09/18/2018 |
GN
| Deciphera Pharmaceuticals Appoints Daniel C. Martin as Chief Commercial Officer |
| 07/25/2018 |
GN
| Analysis: Positioning to Benefit within Xylem, Duluth, Deciphera Pharmaceuticals, Mesabi Trust, Associated Banc-Corp, and AG Mortgage Investment Trust — Research Highlights Growth, Revenue, and Consolidated Results |
| 05/18/2018 |
GN
| Market Trends Toward New Normal in CPB, Deciphera Pharmaceuticals, Masonite International, First Internet, Duluth, and Virtus Investment Partners — Emerging Consolidated Expectations, Analyst Ratings |
| 01/24/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for ShotSpotter, Deciphera Pharmaceuticals, Ryman Hospitality Properties, Community Bank System, InfraREIT, and USANA Health Sciences — Fundamental Analysis, Key Performance Indications |
| 12/18/2017 |
GN
| Deciphera Pharmaceuticals, Inc. Added to Russell 2000® Index |
|
|